Literature DB >> 26880772

Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand.

Ratha-korn Vilaichone1, Thawee Ratanachu-Ek2, Pornpen Gamnarai2, Supakarn Chaithongrat2, Tomahisa Uchida2, Yoshio Yamaoka1, Varocha Mahachai2.   

Abstract

This study aimed to survey the prevalence, patterns of antibiotic resistance, and clinical factors associated with antibiotic resistance in Helicobacter pylori among the Karen and Hmong mountain people of Thailand. We recruited dyspeptic patients in the Maesod district, Tak Province, Thailand. All subjects underwent upper gastrointestinal endoscopy, and three antral gastric biopsies were obtained for rapid urease tests and culture. An epsilometer was used to determine the minimum inhibitory concentrations of amoxicillin (AMX), clarithromycin (CLR), metronidazole (MNZ), levofloxacin (LVX), ciprofloxacin (CIP), and tetracycline (TET). A total of 291 subjects were enrolled; 149 (51.2%) were infected with H. pylori. Helicobacter pylori infection was present in 47.1% of Thai, 51.7% of Karen, and 58.7% of Hmong subjects. Antibiotic resistance was present in 75.8% including AMX (0.8%), TET (0%), CLR (5.6%), MNZ (71.8%), CIP (19.4%), LVX (19.4%), and multidrug resistance in 21.8%. Karen subjects had the highest prevalence of MNZ resistance (84.6%), and Hmong subjects had the highest prevalence of fluoroquinolone (27.3%) and multidrug (34.1%) resistance. MNZ plus fluoroquinolone (14.5%) was the most common multidrug resistance. There was no association between clinical factors and antibiotic resistance. MNZ resistance was prevalent, whereas fluoroquinolone- and multidrug-resistant H. pylori infections are important problems in mountain people of Thailand. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26880772      PMCID: PMC4824209          DOI: 10.4269/ajtmh.15-0449

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

Review 1.  Helicobacter pylori diagnosis and management.

Authors:  Ratha-Korn Vilaichone; Varocha Mahachai; David Y Graham
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

2.  Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.

Authors:  Peng Su; Youming Li; Hongzhang Li; Jiakun Zhang; Lang Lin; Qunying Wang; Feng Guo; Zizhong Ji; Jibo Mao; Wuheng Tang; Zhengchao Shi; Wei Shao; Junliang Mao; Xinjian Zhu; Xiaofeng Zhang; Yuefeng Tong; Huimin Tu; Mizu Jiang; Zhiyong Wang; Fengzhe Jin; Ningmin Yang; Jianzhong Zhang
Journal:  Helicobacter       Date:  2013-02-19       Impact factor: 5.753

3.  Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.

Authors:  Chanagune Srinarong; Sith Siramolpiwat; Arti Wongcha-um; Varocha Mahachai; Ratha-korn Vilaichone
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos.

Authors:  Sengdao Vannarath; Ratha-korn Vilaichone; Bouachanh Rasachak; Pisaln Mairiang; Yoshio Yamaoka; Seiji Shiota; Tran Thanh Binh; Varocha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Clinical characteristics and Helicobacter pylori status of gastric cancer in Thailand.

Authors:  Ratha-korn Vilaichone; Wirat Panarat; Surasak Aekpongpaisit; Voracha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Helicobacter pylori infection impacts on functional dyspepsia in Thailand.

Authors:  Kitiyawadee Piriyapong; Anupong Tangaroonsanti; Varocha Mahachai; Ratha-Korn Vilaichone
Journal:  Asian Pac J Cancer Prev       Date:  2014

7.  Nationwide survey of Helicobacter pylori antibiotic resistance in Thailand.

Authors:  Ratha-Korn Vilaichone; Pornpen Gumnarai; Thawee Ratanachu-Ek; Varocha Mahachai
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-04       Impact factor: 2.803

8.  Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.

Authors:  Lyudmila Boyanova; Ivan Mitov
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

9.  Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.

Authors:  Sanchai Prasertpetmanee; Varocha Mahachai; Ratha-korn Vilaichone
Journal:  Helicobacter       Date:  2013-01-29       Impact factor: 5.753

Review 10.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

View more
  4 in total

1.  A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China.

Authors:  Yan Zhou; Zishao Zhong; Shengjuan Hu; Jing Wang; Yanhong Deng; Ximei Li; Xianmei Chen; Xue Li; Yuanyuan Tang; Xiaofei Li; Qian Hao; Jun Liu; Tian Sang; Yang Bo; Feihu Bai
Journal:  Antimicrob Agents Chemother       Date:  2022-06-02       Impact factor: 5.938

2.  High Fluoroquinolone Resistant Strains of Helicobacter pylori in the Golden triangle

Authors:  Ratha Korn Vilaichone; Thawee Ratanachu ek; Pornpen Gamnarai; Phawinee Subsomwong; Tomahisa Uchida; Yoshio Yamaoka; Varocha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

3.  Low Re-infection Rate of Helicobacter pylori after Successful Eradication in Thailand: A 2 Years Study

Authors:  Ratha Korn Vilaichone; Arti Wongcha Um; Peranart Chotivitayatarakorn
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

4.  Adapted first-line treatment of Helicobacter pylori infection in Algerian children.

Authors:  Mostefa Moubri; Nicolas Kalach; Rezki Larras; Hassina Berrah; Fouzia Mouffok; Zhor Guechi; Samy Cadranel
Journal:  Ann Gastroenterol       Date:  2018-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.